- ►diabetesjournals.org TQ Nguyen, L Tarnow, S Andersen, P Hovind … - Diabetes care, 2006 - Am Diabetes Assoc OBJECTIVE—Levels of connective tissue growth factor (CTGF; CCN-2) in plasma
are increased in various fibrotic disorders, including diabetic nephropathy.
Recently, several articles have reported a strong increase of urinary CTGF ... Cited by 34 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org P Roestenberg, FA van Nieuwenhoven, L … - Diabetes Care, 2004 - Am Diabetes Assoc OBJECTIVE—Connective tissue growth factor (CTGF) is strongly upregulated in
fibrotic disorders and has been hypothesized to play a role in the development
and progression of diabetes complications. The aim of the present study was ... Cited by 66 - Related articles - BL Direct - All 6 versions
BL Riser, P Cortes, M Denichilo, PV … - Kidney international, 2003 - nature.com It is currently impossible to reliably predict which diabetic patients will
develop nephropathy and progress to kidney failure. Microalbuminuria, often
regarded as a predictor of overt diabetic renal disease is, in fact, an ... Cited by 59 - Related articles - BL Direct - All 4 versions
- ►physiology.org [PDF] P Roestenberg, FA van Nieuwenhoven, JA … - American Journal of Physiology- Renal Physiology, 2006 - Am Physiological Soc 59 articles, 37 of which you can access free at: This article cites
http://ajprenal.physiology.org/cgi/content/full/290/6/F1344#BIBL ... 6 other
HighWire hosted articles, the first 5 are: This article has been cited by Cited by 38 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org RE Gilbert, A Akdeniz, S Weitz, WR Usinger … - Diabetes Care, 2003 - Am Diabetes Assoc OBJECTIVE—Excretion of growth factors in the urine has been implicated in the
pathogenesis of tubulointerstitial disease that characterizes proteinuric renal
disease. In this cross-sectional study, we sought to examine the urinary ... Cited by 61 - Related articles - BL Direct - All 5 versions
- ►fasebj.org M Guha, ZG Xu, D Tung, L Lanting, R … - The FASEB Journal, 2007 - FASEB Diabetic nephropathy (DN) remains a major complication in both type 1 and type 2
diabetes. Systemic administration of antitransforming growth factor-ß (TGF-ß)
antibody has shown some promise in mouse models of DN. However, chronic ... Cited by 33 - Related articles - BL Direct - All 5 versions
F SA, PR LT, LW KR, HP RG - Kidney international, 2005 - nature.com Seventy-one hypertensive type 1 diabetic patients with diabetic nephropathy were
included in the study. After a washout period of 4 weeks, the patients received
Losartan 50 mg, 100 mg, and 150 mg once daily in treatment periods each ... Cited by 34 - Related articles - All 3 versions
[CITATION] Long-term renal effects of a neutralizing connective tissue growth factor (CTGF)-antibody in …
SG Adler, SW Kang, S Feld, DR Cha, L Barba, L … - American Journal of Kidney Diseases, 2002 - Elsevier From the Division of Nephrology and Hypertension, Harbor-UCLA Research and
Education Institute Torrance, CA; Department of Medicine, University of Miami,
Miami, FL; Division of Nephrology, Henry Ford Hospital, Detroit MI; and ... Cited by 24 - Related articles - BL Direct - All 9 versions
